These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 30340769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Foreword.
    Curr Probl Cardiol; 2020 May; 45(5):100559. PubMed ID: 32192631
    [No Abstract] [Full Text] [Related]

  • 3. Cardiovascular disease in transgender people: recent research and emerging evidence.
    Connelly PJ, Delles C.
    Cardiovasc Res; 2021 Dec 17; 117(14):e174-e176. PubMed ID: 34568899
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
    Dutra E, Lee J, Torbati T, Garcia M, Merz CNB, Shufelt C.
    Maturitas; 2019 Nov 17; 129():45-49. PubMed ID: 31547912
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transgender men: clinical care and implications in reproductive medicine: introduction.
    de Ziegler D, de Sutter P.
    Fertil Steril; 2021 Oct 17; 116(4):919-921. PubMed ID: 34399947
    [Abstract] [Full Text] [Related]

  • 7. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C, Monita M, Liu M.
    Climacteric; 2024 Jun 17; 27(3):227-235. PubMed ID: 38597210
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gender identity and the management of the transgender patient: a guide for non-specialists.
    Joseph A, Cliffe C, Hillyard M, Majeed A.
    J R Soc Med; 2017 Apr 17; 110(4):144-152. PubMed ID: 28382847
    [Abstract] [Full Text] [Related]

  • 10. [Psychiatric comorbidities in transsexualism: Study of a Lebanese transgender population].
    Ibrahim C, Haddad R, Richa S.
    Encephale; 2016 Dec 17; 42(6):517-522. PubMed ID: 27017319
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA, Georgakis MK, Dimitriou NG, Vichos T, Katsimpris A, Petridou ET, Papadopoulos FC.
    Psychoneuroendocrinology; 2020 Sep 17; 119():104721. PubMed ID: 32512250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Priorities for transgender medical and healthcare research.
    Feldman J, Brown GR, Deutsch MB, Hembree W, Meyer W, Meyer-Bahlburg HF, Tangpricha V, TʼSjoen G, Safer JD.
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr 17; 23(2):180-7. PubMed ID: 26825469
    [Abstract] [Full Text] [Related]

  • 17. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK, Mullins ES.
    J Thromb Haemost; 2024 Aug 17; 22(8):2129-2139. PubMed ID: 38795871
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Research priorities for gender nonconforming/transgender youth: gender identity development and biopsychosocial outcomes.
    Olson-Kennedy J, Cohen-Kettenis PT, Kreukels BP, Meyer-Bahlburg HF, Garofalo R, Meyer W, Rosenthal SM.
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr 17; 23(2):172-9. PubMed ID: 26825472
    [Abstract] [Full Text] [Related]

  • 20. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
    Rowniak S, Bolt L, Sharifi C.
    JBI Database System Rev Implement Rep; 2019 Sep 17; 17(9):1826-1854. PubMed ID: 31021971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.